NEU neuren pharmaceuticals limited

NEU is materially undervalued, page-14

  1. 1,268 Posts.
    lightbulb Created with Sketch. 165
    you have to factor in the wider market, uncertainty in global markets (esp Japan and US), uncertainties in wider biotech indices - although these seem now seem to be in a positive trend - and the uncertainties from the Acadia results. The only thing you can do is to ignore all the speculative comments, consider the genuine valuations from sources that you can respect, and decide if Daybue and 2591 (now with 3 p2 results) justifies the companies current and future valuation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.